Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 201

1.

Sustained diabetes risk reduction after real life and primary health care setting implementation of the diabetes in Europe prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project.

Gilis-Januszewska A, Lindström J, Tuomilehto J, Piwońska-Solska B, Topór-Mądry R, Szybiński Z, Peltonen M, Schwarz PE, Windak A, Hubalewska-Dydejczyk A.

BMC Public Health. 2017 Feb 15;17(1):198. doi: 10.1186/s12889-017-4104-3.

2.

The effects of iodised salt licks and teat dipping on the iodine content of cow's milk and blood plasma.

Śliwiński B, Brzóska F, Węglarzy K, Szybiński Z, Kłopotek E.

Endokrynol Pol. 2015;66(3):244-50. doi: 10.5603/EP.2015.0032.

3.

Screening for people with abnormal glucose metabolism in the European DE-PLAN project.

Cos FX, Barengo NC, Costa B, Mundet-Tudurí X, Lindström J, Tuomilehto JO; DE-PLAN Study Group..

Diabetes Res Clin Pract. 2015 Jul;109(1):149-56. doi: 10.1016/j.diabres.2015.04.016.

PMID:
25931281
4.

The memory on Prof. Aldo Pinchera M.D., Ph.D.

Szybiński Z, Nauman J.

Endokrynol Pol. 2013;64(1):78-9. No abstract available.

PMID:
23450451
5.

Work of the Polish Council for Control of Iodine Deficiency Disorders, and the model of iodine prophylaxis in Poland.

Szybiński Z; Polish Council for Control of Iodine Deficiency Disorders..

Endokrynol Pol. 2012;63(2):156-60.

PMID:
22538756
6.

Reference values for thyroid volume established by ultrasound in Polish schoolchildren.

Szybiński Z, Trofimiuk-Müldner M, Buziak-Bereza M, Walczycka L, Hubalewska-Dydejczyk A.

Endokrynol Pol. 2012;63(2):104-9.

PMID:
22538748
7.

[Assessement of the usefulness of whole body scintigraphy after administration of 6 MBq of 131I in the diagnostic of breast cancer].

Gołkowski F, Sokołowski G, Gil J, Kostecka-Matyja M, Basta P, Sowa-Staszczak A, Szybiński Z, Hubalewska-Dydejczyk A.

Przegl Lek. 2011;68(2):92-5. Polish.

PMID:
21751517
8.
9.

Prognostic impact of electrocardiographic signs in patients with Type 2 diabetes and cardiovascular disease: results from the PROactive study.

Pfister R, Cairns R, Erdmann E, Schneider CA; PROactive investigators..

Diabet Med. 2011 Oct;28(10):1206-12. doi: 10.1111/j.1464-5491.2011.03281.x.

PMID:
21388447
10.

Quality indicators for the prevention of type 2 diabetes in Europe--IMAGE.

Pajunen P, Landgraf R, Muylle F, Neumann A, Lindström J, Schwarz PE, Peltonen M, Acosta T, Adler M, AlKerwi A, Barengo N, Barengo R, Boavida JM, Charlesworth K, Christov V, Claussen B, Cos X, Cosson E, Deceukelier S, Dimitrijevic-Sreckovic V, Djordjevic P, Evans P, Felton AM, Fischer M, Gabriel-Sanchez R, Gilis-Januszewska A, Goldfracht M, Gomez JL, Greaves CJ, Hall M, Handke U, Hauner H, Herbst J, Hermanns N, Herrebrugh L, Huber C, Hühmer U, Huttunen J, Jotic A, Kamenov Z, Karadeniz S, Katsilambros N, Khalangot M, Kissimova-Skarbek K, Köhler D, Kopp V, Kronsbein P, Kulzer B, Kyne-Grzebalski D, Lalic K, Lalic N, Landgraf R, Lee-Barkey YH, Liatis S, Lindström J, Makrilakis K, McIntosh C, McKee M, Mesquita AC, Misina D, Muylle F, Neumann A, Paiva AC, Pajunen P, Paulweber B, Peltonen M, Perrenoud L, Pfeiffer A, Pölönen A, Puhl S, Raposo F, Reinehr T, Rissanen A, Robinson C, Roden M, Rothe U, Saaristo T, Scholl J, Schwarz PE, Sheppard KE, Spiers S, Stemper T, Stratmann B, Szendroedi J, Szybinski Z, Tankova T, Telle-Hjellset V, Terry G, Tolks D, Toti F, Tuomilehto J, Undeutsch A, Valadas C, Valensi P, Velickiene D, Vermunt P, Weiss R, Wens J, Yilmaz T.

Horm Metab Res. 2010 Apr;42 Suppl 1:S56-63. doi: 10.1055/s-0029-1240976.

PMID:
20391308
11.

Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe.

Lindström J, Neumann A, Sheppard KE, Gilis-Januszewska A, Greaves CJ, Handke U, Pajunen P, Puhl S, Pölönen A, Rissanen A, Roden M, Stemper T, Telle-Hjellset V, Tuomilehto J, Velickiene D, Schwarz PE, Acosta T, Adler M, AlKerwi A, Barengo N, Barengo R, Boavida JM, Charlesworth K, Christov V, Claussen B, Cos X, Cosson E, Deceukelier S, Dimitrijevic-Sreckovic V, Djordjevic P, Evans P, Felton AM, Fischer M, Gabriel-Sanchez R, Gilis-Januszewska A, Goldfracht M, Gomez JL, Greaves CJ, Hall M, Handke U, Hauner H, Herbst J, Hermanns N, Herrebrugh L, Huber C, Hühmer U, Huttunen J, Jotic A, Kamenov Z, Karadeniz S, Katsilambros N, Khalangot M, Kissimova-Skarbek K, Köhler D, Kopp V, Kronsbein P, Kulzer B, Kyne-Grzebalski D, Lalic K, Lalic N, Landgraf R, Lee-Barkey YH, Liatis S, Lindström J, Makrilakis K, McIntosh C, McKee M, Mesquita AC, Misina D, Muylle F, Neumann A, Paiva AC, Pajunen P, Paulweber B, Peltonen M, Perrenoud L, Pfeiffer A, Pölönen A, Puhl S, Raposo F, Reinehr T, Rissanen A, Robinson C, Roden M, Rothe U, Saaristo T, Scholl J, Schwarz PE, Sheppard KE, Spiers S, Stemper T, Stratmann B, Szendroedi J, Szybinski Z, Tankova T, Telle-Hjellset V, Terry G, Tolks D, Toti F, Tuomilehto J, Undeutsch A, Valadas C, Valensi P, Velickiene D, Vermunt P, Weiss R, Wens J, Yilmaz T.

Horm Metab Res. 2010 Apr;42 Suppl 1:S37-55. doi: 10.1055/s-0029-1240975.

PMID:
20391307
12.

A European evidence-based guideline for the prevention of type 2 diabetes.

Paulweber B, Valensi P, Lindström J, Lalic NM, Greaves CJ, McKee M, Kissimova-Skarbek K, Liatis S, Cosson E, Szendroedi J, Sheppard KE, Charlesworth K, Felton AM, Hall M, Rissanen A, Tuomilehto J, Schwarz PE, Roden M, Paulweber M, Stadlmayr A, Kedenko L, Katsilambros N, Makrilakis K, Kamenov Z, Evans P, Gilis-Januszewska A, Lalic K, Jotic A, Djordevic P, Dimitrijevic-Sreckovic V, Hühmer U, Kulzer B, Puhl S, Lee-Barkey YH, AlKerwi A, Abraham C, Hardeman W, Acosta T, Adler M, AlKerwi A, Barengo N, Barengo R, Boavida JM, Charlesworth K, Christov V, Claussen B, Cos X, Cosson E, Deceukelier S, Dimitrijevic-Sreckovic V, Djordjevic P, Evans P, Felton AM, Fischer M, Gabriel-Sanchez R, Gilis-Januszewska A, Goldfracht M, Gomez JL, Greaves CJ, Hall M, Handke U, Hauner H, Herbst J, Hermanns N, Herrebrugh L, Huber C, Hühmer U, Huttunen J, Jotic A, Kamenov Z, Karadeniz S, Katsilambros N, Khalangot M, Kissimova-Skarbek K, Köhler D, Kopp V, Kronsbein P, Kulzer B, Kyne-Grzebalski D, Lalic K, Lalic N, Landgraf R, Lee-Barkey YH, Liatis S, Lindström J, Makrilakis K, McIntosh C, McKee M, Mesquita AC, Misina D, Muylle F, Neumann A, Paiva AC, Pajunen P, Paulweber B, Peltonen M, Perrenoud L, Pfeiffer A, Pölönen A, Puhl S, Raposo F, Reinehr T, Rissanen A, Robinson C, Roden M, Rothe U, Saaristo T, Scholl J, Schwarz PE, Sheppard KE, Spiers S, Stemper T, Stratmann B, Szendroedi J, Szybinski Z, Tankova T, Telle-Hjellset V, Terry G, Tolks D, Toti F, Tuomilehto J, Undeutsch A, Valadas C, Valensi P, Velickiene D, Vermunt P, Weiss R, Wens J, Yilmaz T.

Horm Metab Res. 2010 Apr;42 Suppl 1:S3-36. doi: 10.1055/s-0029-1240928.

PMID:
20391306
13.

Iodine-deficiency prophylaxis and the restriction of salt consumption - a 21st century challenge.

Szybiński Z, Jarosz M, Hubalewska-Dydejczyk A, Stolarz-Skrzypek K, Kawecka-Jaszcz K, Traczyk I, Stoś K.

Endokrynol Pol. 2010 Jan-Feb;61(1):135-40. Review.

14.

Iodine, selenium, and other trace elements in urine of pregnant women.

Szybiński Z, Walas S, Zagrodzki P, Sokołowski G, Gołkowski F, Mrowiec H.

Biol Trace Elem Res. 2010 Dec;138(1-3):28-41. doi: 10.1007/s12011-009-8601-9.

PMID:
20094821
15.

[Iodine-deficiency prophylaxis and the restriction of salt consumption--a 21st century challenge].

Szybiński Z, Jarosz M, Hubalewska-Dydejczyk A, Stolarz-Skrzypek K, Kawecka-Jaszcz K, Traczyk I, Stoś K.

Endokrynol Pol. 2010;61 Suppl 1:1-6. Review. Polish.

PMID:
22127630
16.

Iodine concentration in Polish milk - variations due to season and region.

Brzóska F, Szybiński Z, Sliwiński B.

Endokrynol Pol. 2009 Nov-Dec;60(6):449-54.

PMID:
20041362
17.

[Iodine prophylaxis in Poland in light of the WHO recommendation on reduction of the daily salt intake].

Szybiński Z.

Pediatr Endocrinol Diabetes Metab. 2009;15(2):103-7. Review. Polish.

PMID:
19772817
18.

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.

Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Team..

Lancet. 2009 Jun 20;373(9681):2125-35. doi: 10.1016/S0140-6736(09)60953-3.

PMID:
19501900
19.

Bimodal distribution of glucose is not universally useful for diagnosing diabetes.

Vistisen D, Colagiuri S, Borch-Johnsen K; DETECT-2 Collaboration..

Diabetes Care. 2009 Mar;32(3):397-403. doi: 10.2337/dc08-0867.

20.

Effectiveness of the iodine prophylaxis model adopted in Poland.

Szybinski Z, Golkowski F, Buziak-Bereza M, Trofimiuk M, Przybylik-Mazurek E, Huszno B, Bandurska-Stankiewicz E, Bar-Andziak E, Dorant B, Kinalska I, Lewinski A, Klencki M, Rybakowa M, Sowinski J, Szewczyk L, Szponar L, Wasik R.

J Endocrinol Invest. 2008 Apr;31(4):309-13.

PMID:
18475048

Supplemental Content

Loading ...
Support Center